Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Ovarian Res
Where should I inject AOD-9604
Manufactured by GSK, this groundbreaking oral gonorrhea antibiotic received FDA approval December 10, 2025, following successful completion of the global EAGLE-1 phase III clinical trial. The EAGLE-1 trial enrolled approximately 628 patients with uncomplicated urogenital gonorrhea, with half receiving two 3,000 mg doses of Blujepa taken 10 to 12 hours apart
For weight management purposes, B12 injections are not clinically indicated unless deficiency is documented
Subcutaneous AOD-9604 Community research plans often cite 300-500 mcg per day from a reconstituted vial
US$ 22.69
US$ 26.38
US$ 23.30
US$ 23.80
